Growth Metrics

Adma Biologics (ADMA) Leases (2016 - 2025)

Historic Leases for Adma Biologics (ADMA) over the last 10 years, with Q3 2025 value amounting to $9.3 million.

  • Adma Biologics' Leases rose 420.37% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 420.37%. This contributed to the annual value of $8.6 million for FY2024, which is 1038.92% down from last year.
  • As of Q3 2025, Adma Biologics' Leases stood at $9.3 million, which was up 420.37% from $9.0 million recorded in Q2 2025.
  • Adma Biologics' 5-year Leases high stood at $10.6 million for Q2 2022, and its period low was $6.2 million during Q1 2021.
  • For the 5-year period, Adma Biologics' Leases averaged around $8.8 million, with its median value being $9.2 million (2024).
  • Its Leases has fluctuated over the past 5 years, first surged by 14042.31% in 2021, then plummeted by 1465.36% in 2025.
  • Adma Biologics' Leases (Quarter) stood at $7.3 million in 2021, then soared by 44.37% to $10.5 million in 2022, then dropped by 8.11% to $9.6 million in 2023, then dropped by 10.39% to $8.6 million in 2024, then grew by 7.38% to $9.3 million in 2025.
  • Its Leases was $9.3 million in Q3 2025, compared to $9.0 million in Q2 2025 and $8.0 million in Q1 2025.